Neogenomics, Inc.
NEO
$7.88
-$0.10-1.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.03M | -113.47M | -104.04M | -77.59M | -78.73M |
| Total Depreciation and Amortization | 67.82M | 69.62M | 71.17M | 72.01M | 72.55M |
| Total Amortization of Deferred Charges | 2.00M | 2.35M | 2.70M | 2.92M | 2.91M |
| Total Other Non-Cash Items | 75.53M | 75.72M | 67.04M | 45.03M | 42.92M |
| Change in Net Operating Assets | -32.10M | -20.53M | -22.81M | -34.76M | -32.63M |
| Cash from Operations | 5.23M | 13.69M | 14.05M | 7.61M | 7.02M |
| Capital Expenditure | -27.01M | -30.74M | -33.22M | -39.98M | -41.06M |
| Sale of Property, Plant, and Equipment | 2.07M | -- | -- | -- | -- |
| Cash Acquisitions | -6.45M | -6.45M | -5.99M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.06M | 25.69M | 24.48M | 41.87M | 53.92M |
| Cash from Investing | -12.34M | -11.50M | -14.74M | 1.89M | 12.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -201.25M | -201.25M | -201.25M | -- | -- |
| Issuance of Common Stock | 1.91M | 5.02M | 5.67M | 7.63M | 7.50M |
| Repurchase of Common Stock | -949.00K | -949.00K | -949.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -2.86M | -3.09M | -2.86M | -2.86M |
| Cash from Financing | -200.29M | -200.03M | -199.62M | 4.78M | 4.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -32.00K | -54.00K | -- | -- |
| Net Change in Cash | -207.39M | -197.88M | -200.36M | 14.28M | 24.52M |